In support of the anti-tumor function of AIM2 in BC, Chen et al. [36] demonstrated that the manipulation of the AIM2 gene inhibited mammary tumor growth in an orthotopic model of BC [36], paving the way for the possible application of gene therapy for BC patients based on overexpressing AIM2. Here, AIM2 is linked to neoplasm.